Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities
Launched by UNIVERSIDAD DE ZARAGOZA · Sep 21, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a special computer program designed to stimulate thinking skills works compared to fun leisure activities for older adults who have mild cognitive impairment (MCI). MCI can make it harder to remember things or think clearly, and this trial aims to find out which activity helps improve overall thinking abilities, memory, and daily living skills, as well as mood and anxiety levels. The study is open to men and women aged 50 and over who live in the community and have been diagnosed with MCI or have some concerns about their thinking abilities.
If you're interested in participating, you'll need to meet certain criteria, such as being at least 50 years old and having either a diagnosis of MCI or specific cognitive scores that indicate mild issues. However, if you're currently living in a care facility, taking certain medications for cognitive issues, or have significant sensory impairments, you may not be eligible. Participants can expect to engage in either the computer program or leisure activities and will be assessed on various aspects of their cognitive health throughout the study. It's a great opportunity to contribute to research that may help improve the lives of people with cognitive challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 50 years old, resident in the community.
- • Diagnosis of MCI or having between 24 and 27 points on the MEC-35 (this score seems to indicate the presence of MCI) (Calero, M. D and Navarro, 2006).
- • Subjective cognitive impairment (score between 28-31 points on the MEC-35) (Gómez-Soria et al. 2023)
- Exclusion Criteria:
- • Institutionalisation.
- • Taking acetylcholinesterase inhibitors as they may act on global cognition and/or cognitive functions.
- • Sensory deficits (deafness and blindness) preventing intervention.
- • Agitation.
- • Having received cognitive stimulation in the last 12 months.
About Universidad De Zaragoza
The Universidad de Zaragoza, a prestigious institution in Spain, is dedicated to advancing scientific research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration, the university fosters a robust environment for conducting high-quality clinical studies that aim to improve healthcare outcomes. Leveraging its extensive academic resources and expertise across various medical fields, the Universidad de Zaragoza is committed to ethical research practices and the promotion of evidence-based medicine, contributing to the advancement of knowledge and the betterment of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaragoza, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported